Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 254

1.

Enabling precision medicine via standard communication of HTS provenance, analysis, and results.

Alterovitz G, Dean D, Goble C, Crusoe MR, Soiland-Reyes S, Bell A, Hayes A, Suresh A, Purkayastha A, King CH, Taylor D, Johanson E, Thompson EE, Donaldson E, Morizono H, Tsang H, Vora JK, Goecks J, Yao J, Almeida JS, Keeney J, Addepalli K, Krampis K, Smith KM, Guo L, Walderhaug M, Schito M, Ezewudo M, Guimera N, Walsh P, Kahsay R, Gottipati S, Rodwell TC, Bloom T, Lai Y, Simonyan V, Mazumder R.

PLoS Biol. 2018 Dec 31;16(12):e3000099. doi: 10.1371/journal.pbio.3000099. eCollection 2018 Dec.

2.

Acute Flavivirus and Alphavirus Infections among Children in Two Different Areas of Kenya, 2015.

Hortion J, Mutuku FM, Eyherabide AL, Vu DM, Boothroyd DB, Grossi-Soyster EN, King CH, Ndenga BA, LaBeaud AD.

Am J Trop Med Hyg. 2019 Jan;100(1):170-173. doi: 10.4269/ajtmh.18-0297.

PMID:
30457092
3.

Accuracy of the WHO praziquantel dose pole for large-scale community treatment of urogenital schistosomiasis in northern Mozambique: Is it time for an update?

Gazzinelli-Guimaraes PH, Dhanani N, King CH, Campbell CH, Aurelio HO, Ferro J, Nala R, Fenwick A, Phillips AE.

PLoS Negl Trop Dis. 2018 Nov 15;12(11):e0006957. doi: 10.1371/journal.pntd.0006957. eCollection 2018 Nov.

4.

The design of schistosomiasis monitoring and evaluation programmes: The importance of collecting adult data to inform treatment strategies for Schistosoma mansoni.

Toor J, Turner HC, Truscott JE, Werkman M, Phillips AE, Alsallaq R, Medley GF, King CH, Anderson RM.

PLoS Negl Trop Dis. 2018 Oct 8;12(10):e0006717. doi: 10.1371/journal.pntd.0006717. eCollection 2018 Oct.

5.

Schistosomiasis in Africa: Improving strategies for long-term and sustainable morbidity control.

French MD, Evans D, Fleming FM, Secor WE, Biritwum NK, Brooker SJ, Bustinduy A, Gouvras A, Kabatereine N, King CH, Rebollo Polo M, Reinhard-Rupp J, Rollinson D, Tchuem Tchuenté LA, Utzinger J, Waltz J, Zhang Y.

PLoS Negl Trop Dis. 2018 Jun 28;12(6):e0006484. doi: 10.1371/journal.pntd.0006484. eCollection 2018 Jun. No abstract available.

6.

Are We on Our Way to Achieving the 2020 Goals for Schistosomiasis Morbidity Control Using Current World Health Organization Guidelines?

Toor J, Alsallaq R, Truscott JE, Turner HC, Werkman M, Gurarie D, King CH, Anderson RM.

Clin Infect Dis. 2018 Jun 1;66(suppl_4):S245-S252. doi: 10.1093/cid/ciy001.

7.

The human-snail transmission environment shapes long term schistosomiasis control outcomes: Implications for improving the accuracy of predictive modeling.

Gurarie D, Lo NC, Ndeffo-Mbah ML, Durham DP, King CH.

PLoS Negl Trop Dis. 2018 May 21;12(5):e0006514. doi: 10.1371/journal.pntd.0006514. eCollection 2018 May.

8.

Nasopharyngeal Carriage of Streptococcus pneumoniae in Children in Coastal Kenya.

Heath CJ, Nayakwadi-Singer M, King CH, Malhotra I, Mutuku F, Mukoko D, LaBeaud AD.

Am J Trop Med Hyg. 2018 Apr;98(4):1046-1050. doi: 10.4269/ajtmh.16-0813. Epub 2018 Feb 22.

PMID:
29488456
9.

Latent class analysis to evaluate performance of point-of-care CCA for low-intensity Schistosoma mansoni infections in Burundi.

Clements MN, Corstjens PLAM, Binder S, Campbell CH Jr, de Dood CJ, Fenwick A, Harrison W, Kayugi D, King CH, Kornelis D, Ndayishimiye O, Ortu G, Lamine MS, Zivieri A, Colley DG, van Dam GJ.

Parasit Vectors. 2018 Feb 23;11(1):111. doi: 10.1186/s13071-018-2700-4.

10.

Underestimation of the global burden of schistosomiasis.

King CH, Galvani AP.

Lancet. 2018 Jan 27;391(10118):307-308. doi: 10.1016/S0140-6736(18)30098-9. Epub 2018 Jan 31. No abstract available.

PMID:
29413041
11.

Mapping Out the under-Recognized Burden of Human Infertility Linked to Schistosoma haematobium Infection.

King CH.

Am J Trop Med Hyg. 2018 Apr;98(4):937-938. doi: 10.4269/ajtmh.17-1016. Epub 2018 Feb 1. No abstract available.

12.

Cord Blood Antiparasite Interleukin 10 as a Risk Marker for Compromised Vaccine Immunogenicity in Early Childhood.

Malhotra I, LaBeaud AD, Morris N, McKibben M, Mungai P, Muchiri E, King CL, King CH.

J Infect Dis. 2018 Apr 11;217(9):1426-1434. doi: 10.1093/infdis/jiy047.

PMID:
29390149
13.

Historical perspective: Revisiting the St. Lucia Project, a multi-year comparison trial of schistosomiasis control strategies.

Ivy JA, King CH, Cook JA, Colley DG.

PLoS Negl Trop Dis. 2018 Jan 31;12(1):e0006223. doi: 10.1371/journal.pntd.0006223. eCollection 2018 Jan. No abstract available.

14.

Cognitive deficits and educational loss in children with schistosome infection-A systematic review and meta-analysis.

Ezeamama AE, Bustinduy AL, Nkwata AK, Martinez L, Pabalan N, Boivin MJ, King CH.

PLoS Negl Trop Dis. 2018 Jan 12;12(1):e0005524. doi: 10.1371/journal.pntd.0005524. eCollection 2018 Jan. Review.

15.

Impact and cost-effectiveness of snail control to achieve disease control targets for schistosomiasis.

Lo NC, Gurarie D, Yoon N, Coulibaly JT, Bendavid E, Andrews JR, King CH.

Proc Natl Acad Sci U S A. 2018 Jan 23;115(4):E584-E591. doi: 10.1073/pnas.1708729114. Epub 2018 Jan 4.

16.

Assessing the benefits of five years of different approaches to treatment of urogenital schistosomiasis: A SCORE project in Northern Mozambique.

Phillips AE, Gazzinelli-Guimaraes PH, Aurelio HO, Ferro J, Nala R, Clements M, King CH, Fenwick A, Fleming FM, Dhanani N.

PLoS Negl Trop Dis. 2017 Dec 8;11(12):e0006061. doi: 10.1371/journal.pntd.0006061. eCollection 2017 Dec.

17.

Cross-sectional interview study of fertility, pregnancy, and urogenital schistosomiasis in coastal Kenya: Documented treatment in childhood is associated with reduced odds of subfertility among adult women.

Miller-Fellows SC, Howard L, Kramer R, Hildebrand V, Furin J, Mutuku FM, Mukoko D, Ivy JA, King CH.

PLoS Negl Trop Dis. 2017 Nov 27;11(11):e0006101. doi: 10.1371/journal.pntd.0006101. eCollection 2017 Nov.

18.

Systematic review of community-based, school-based, and combined delivery modes for reaching school-aged children in mass drug administration programs for schistosomiasis.

Burnim M, Ivy JA, King CH.

PLoS Negl Trop Dis. 2017 Oct 27;11(10):e0006043. doi: 10.1371/journal.pntd.0006043. eCollection 2017 Oct. Review.

19.

Defining Persistent Hotspots: Areas That Fail to Decrease Meaningfully in Prevalence after Multiple Years of Mass Drug Administration with Praziquantel for Control of Schistosomiasis.

Kittur N, Binder S, Campbell CH, King CH, Kinung'hi S, Olsen A, Magnussen P, Colley DG.

Am J Trop Med Hyg. 2017 Dec;97(6):1810-1817. doi: 10.4269/ajtmh.17-0368. Epub 2017 Sep 21.

20.

Protocol and baseline data for a multi-year cohort study of the effects of different mass drug treatment approaches on functional morbidities from schistosomiasis in four African countries.

Shen Y, King CH, Binder S, Zhang F, Whalen CC, Evan Secor W, Montgomery SP, Mwinzi PNM, Olsen A, Magnussen P, Kinung'hi S, Phillips AE, Nalá R, Ferro J, Aurelio HO, Fleming F, Garba A, Hamidou A, Fenwick A, Campbell CH Jr, Colley DG.

BMC Infect Dis. 2017 Sep 29;17(1):652. doi: 10.1186/s12879-017-2738-5.

21.

The global burden of disease study 2013: What does it mean for the NTDs?

Herricks JR, Hotez PJ, Wanga V, Coffeng LE, Haagsma JA, Basáñez MG, Buckle G, Budke CM, Carabin H, Fèvre EM, Fürst T, Halasa YA, King CH, Murdoch ME, Ramaiah KD, Shepard DS, Stolk WA, Undurraga EA, Stanaway JD, Naghavi M, Murray CJL.

PLoS Negl Trop Dis. 2017 Aug 3;11(8):e0005424. doi: 10.1371/journal.pntd.0005424. eCollection 2017 Aug. No abstract available.

22.

The substructure of three repetitive DNA regions of Schistosoma haematobium group species as a potential marker for species recognition and interbreeding detection.

Abbasi I, Webster BL, King CH, Rollinson D, Hamburger J.

Parasit Vectors. 2017 Aug 1;10(1):364. doi: 10.1186/s13071-017-2281-7.

23.

Change in children's school behavior after mass administration of praziquantel for Schistosoma mansoni infection in endemic areas of western Kenya: A pilot study using the Behavioral Assessment System for Children (BASC-2).

Musuva R, Shen Y, Wei X, Binder S, Ivy JA, Secor WE, Montgomery SP, King CH, Mwinzi PNM.

PLoS One. 2017 Jul 26;12(7):e0181975. doi: 10.1371/journal.pone.0181975. eCollection 2017.

24.

Rift Valley Fever Seroprevalence in Coastal Kenya.

Grossi-Soyster EN, Banda T, Teng CY, Muchiri EM, Mungai PL, Mutuku FM, Gildengorin G, Kitron U, King CH, Desiree Labeaud A.

Am J Trop Med Hyg. 2017 Jul;97(1):115-120. doi: 10.4269/ajtmh.17-0104.

25.

Pharmacologic Properties of Novel Local Anesthetic Agents in Anesthesia Practice.

King CH, Beutler SS, Kaye AD, Urman RD.

Anesthesiol Clin. 2017 Jun;35(2):315-325. doi: 10.1016/j.anclin.2017.01.019. Epub 2017 Apr 14. Review.

PMID:
28526152
26.

The evolving schistosomiasis agenda 2007-2017-Why we are moving beyond morbidity control toward elimination of transmission.

King CH.

PLoS Negl Trop Dis. 2017 Apr 20;11(4):e0005517. doi: 10.1371/journal.pntd.0005517. eCollection 2017 Apr. No abstract available.

27.

Parasitic Infections in Pregnancy Decrease Placental Transfer of Antipneumococcus Antibodies.

McKittrick ND, Vu DM, Malhotra I, King CH, Mutuku F, LaBeaud AD.

Clin Vaccine Immunol. 2017 Jun 5;24(6). pii: e00039-17. doi: 10.1128/CVI.00039-17. Print 2017 Jun.

28.

Pneumococcal Vaccine Response After Exposure to Parasites in Utero, in Infancy, or Mid-Childhood.

Nayakwadi Singer M, Heath C, Muinde J, Gildengorin V, Mutuku FM, Vu D, Mukoko D, King CL, Malhotra IJ, King CH, LaBeaud AD.

Pediatrics. 2017 Apr;139(4). pii: e20162781. doi: 10.1542/peds.2016-2781. Epub 2017 Mar 16.

29.

A comparison of two mathematical models of the impact of mass drug administration on the transmission and control of schistosomiasis.

Truscott JE, Gurarie D, Alsallaq R, Toor J, Yoon N, Farrell SH, Turner HC, Phillips AE, Aurelio HO, Ferro J, King CH, Anderson RM.

Epidemics. 2017 Mar;18:29-37. doi: 10.1016/j.epidem.2017.02.003.

30.

One hundred years of neglect in paediatric schistosomiasis.

Bustinduy AL, Wright S, Joekes EC, Kabatereine NB, Reinhard-Rupp J, King CH, Stothard JR.

Parasitology. 2017 Oct;144(12):1613-1623. doi: 10.1017/S0031182017000014. Epub 2017 Mar 1. Review.

31.

Decline in infection-related morbidities following drug-mediated reductions in the intensity of Schistosoma infection: A systematic review and meta-analysis.

Andrade G, Bertsch DJ, Gazzinelli A, King CH.

PLoS Negl Trop Dis. 2017 Feb 17;11(2):e0005372. doi: 10.1371/journal.pntd.0005372. eCollection 2017 Feb. Review.

32.

Countrywide Reassessment of Schistosoma mansoni Infection in Burundi Using a Urine-Circulating Cathodic Antigen Rapid Test: Informing the National Control Program.

Ortu G, Ndayishimiye O, Clements M, Kayugi D, Campbell CH, Lamine MS, Zivieri A, Magalhaes RS, Binder S, King CH, Fenwick A, Colley DG, Jourdan PM.

Am J Trop Med Hyg. 2017 Mar;96(3):664-673. doi: 10.4269/ajtmh.16-0671. Epub 2017 Apr 6.

33.

Divergent Effects of Schistosoma haematobium Exposure on Intermediate-Host Snail Species Bulinus nasutus and Bulinus globosus from Coastal Kenya.

Kariuki HC, Ivy JA, Muchiri EM, Sutherland LJ, King CH.

Am J Trop Med Hyg. 2017 Apr;96(4):850-855. doi: 10.4269/ajtmh.16-0614. Epub 2017 Jan 23.

34.

Safety of remifentanil in transsphenoidal surgery: A single-center analysis of 540 patients.

Cote DJ, Burke WT, Castlen JP, King CH, Zaidi HA, Smith TR, Laws ER, Aglio LS.

J Clin Neurosci. 2017 Apr;38:96-99. doi: 10.1016/j.jocn.2016.12.011. Epub 2017 Jan 16.

PMID:
28110927
35.

A call to strengthen the global strategy against schistosomiasis and soil-transmitted helminthiasis: the time is now.

Lo NC, Addiss DG, Hotez PJ, King CH, Stothard JR, Evans DS, Colley DG, Lin W, Coulibaly JT, Bustinduy AL, Raso G, Bendavid E, Bogoch II, Fenwick A, Savioli L, Molyneux D, Utzinger J, Andrews JR.

Lancet Infect Dis. 2017 Feb;17(2):e64-e69. doi: 10.1016/S1473-3099(16)30535-7. Epub 2016 Nov 30. Review.

36.

Dengue and West Nile Virus Transmission in Children and Adults in Coastal Kenya.

Vu DM, Banda T, Teng CY, Heimbaugh C, Muchiri EM, Mungai PL, Mutuku FM, Brichard J, Gildengorin G, Borland EM, Powers AM, Kitron U, King CH, LaBeaud AD.

Am J Trop Med Hyg. 2017 Jan 11;96(1):141-143. doi: 10.4269/ajtmh.16-0562. Epub 2016 Nov 7.

37.

Expanding Praziquantel (PZQ) Access beyond Mass Drug Administration Programs: Paving a Way Forward for a Pediatric PZQ Formulation for Schistosomiasis.

Bustinduy AL, Friedman JF, Kjetland EF, Ezeamama AE, Kabatereine NB, Stothard JR, King CH.

PLoS Negl Trop Dis. 2016 Sep 22;10(9):e0004946. doi: 10.1371/journal.pntd.0004946. eCollection 2016 Sep. No abstract available.

39.

Gaining and sustaining schistosomiasis control: study protocol and baseline data prior to different treatment strategies in five African countries.

Ezeamama AE, He CL, Shen Y, Yin XP, Binder SC, Campbell CH Jr, Rathbun S, Whalen CC, N'Goran EK, Utzinger J, Olsen A, Magnussen P, Kinung'hi S, Fenwick A, Phillips A, Ferro J, Karanja DM, Mwinzi PN, Montgomery S, Secor WE, Hamidou A, Garba A, King CH, Colley DG.

BMC Infect Dis. 2016 May 26;16:229. doi: 10.1186/s12879-016-1575-2.

40.

New approaches to measuring anthelminthic drug efficacy: parasitological responses of childhood schistosome infections to treatment with praziquantel.

Walker M, Mabud TS, Olliaro PL, Coulibaly JT, King CH, Raso G, Scherrer AU, Stothard JR, Sousa-Figueiredo JC, Stete K, Utzinger J, Basáñez MG.

Parasit Vectors. 2016 Jan 27;9:41. doi: 10.1186/s13071-016-1312-0.

41.

Comparison of Schistosoma mansoni Prevalence and Intensity of Infection, as Determined by the Circulating Cathodic Antigen Urine Assay or by the Kato-Katz Fecal Assay: A Systematic Review.

Kittur N, Castleman JD, Campbell CH Jr, King CH, Colley DG.

Am J Trop Med Hyg. 2016 Mar;94(3):605-10. doi: 10.4269/ajtmh.15-0725. Epub 2016 Jan 11. Review.

42.

Systematic Review and Meta-analysis of the Impact of Chemical-Based Mollusciciding for Control of Schistosoma mansoni and S. haematobium Transmission.

King CH, Sutherland LJ, Bertsch D.

PLoS Negl Trop Dis. 2015 Dec 28;9(12):e0004290. doi: 10.1371/journal.pntd.0004290. eCollection 2015 Dec. Review.

43.

Joint China-US Call for Employing a Transdisciplinary Approach to Emerging Infectious Diseases.

Mazet JA, Wei Q, Zhao G, Cummings DA, Desmond JS, Rosenthal J, King CH, Cao W, Chmura AA, Hagan EA, Zhang S, Xiao X, Xu J, Shi Z, Feng F, Liu X, Pan W, Zhu G, Zuo L, Daszak P.

Ecohealth. 2015 Dec;12(4):555-9. doi: 10.1007/s10393-015-1060-1. Epub 2015 Dec 8. No abstract available.

44.

Use of prospective hospital surveillance data to define spatiotemporal heterogeneity of malaria risk in coastal Kenya.

Bisanzio D, Mutuku F, LaBeaud AD, Mungai PL, Muinde J, Busaidy H, Mukoko D, King CH, Kitron U.

Malar J. 2015 Dec 1;14:482. doi: 10.1186/s12936-015-1006-7.

45.

Exploring Self-Reported Benefits of Auricular Acupuncture Among Veterans With Posttraumatic Stress Disorder.

King CH, Moore LC, Spence CD.

J Holist Nurs. 2016 Sep;34(3):291-9. doi: 10.1177/0898010115610050. Epub 2015 Nov 3.

PMID:
26530240
46.

Modelling control of Schistosoma haematobium infection: predictions of the long-term impact of mass drug administration in Africa.

Gurarie D, Yoon N, Li E, Ndeffo-Mbah M, Durham D, Phillips AE, Aurelio HO, Ferro J, Galvani AP, King CH.

Parasit Vectors. 2015 Oct 22;8:529. doi: 10.1186/s13071-015-1144-3.

47.

Defining the Necessary Next Steps for Effective Control of Helminthic Infections.

King CH.

Clin Infect Dis. 2016 Jan 15;62(2):208-9. doi: 10.1093/cid/civ833. Epub 2015 Sep 25. No abstract available.

PMID:
26409065
48.

Anemia Among Children Exposed to Polyparasitism in Coastal Kenya.

Chang Cojulun A, Bustinduy AL, Sutherland LJ, Mungai PL, Mutuku F, Muchiri E, Kitron U, King CH.

Am J Trop Med Hyg. 2015 Nov;93(5):1099-105. doi: 10.4269/ajtmh.15-0353. Epub 2015 Aug 31.

49.
50.

Toward Measuring Schistosoma Response to Praziquantel Treatment with Appropriate Descriptors of Egg Excretion.

Olliaro PL, Vaillant M, Diawara A, Coulibaly JT, Garba A, Keiser J, King CH, Knopp S, Landouré A, N'Goran EK, Raso G, Scherrer AU, Sousa-Figueiredo JC, Stete K, Zhou XN, Utzinger J.

PLoS Negl Trop Dis. 2015 Jun 18;9(6):e0003821. doi: 10.1371/journal.pntd.0003821. eCollection 2015.

Supplemental Content

Support Center